SLC5A5 and breast cancer: Over the past two decades, a high abundance of NIS gene expression was reported in BC cases from many parts of the world.7, 8, 9, 10,23,24 Such reports have led to the enthusiastic proposition for its use as a therapeutic gene candidate for targeted radio-iodine therapy in BC-affected patients.